top of page

Om Tioex

Sebastian Siemiatkowski
Niklas Adalberth
Victor Jacobsson
Notable investors
Sequoia Capital
Index Ventures
A3P Biomedical specializes in advanced prostate cancer diagnostics with the main product Stockholm3, providing a more precise test and clearer results for the patient. The company’s mission is to improve the quality of life of men by radically increasing the precision in prostate cancer diagnostics. A total of SEK 750 million has been invested in clinical studies and product development for Stockholm3. The company headquarters is located in Stockholm with around 30 employees.
Notify me about next live opportunity

An error occurred. Try again later

Your content has been submitted

bottom of page